Search results for "Venous thromboembolism"
Guidelines, studies make recommendations on VTE prophylaxis for inpatients with COVID-19
A new CHEST guideline supports standard-dose anticoagulant thromboprophylaxis, while authors of two recent studies of hypercoagulability called for higher doses.
https://acphospitalist.acponline.org/weekly/archives/2020/06/10/2.htm
10 Jun 2020
Iron/EPO combination beats other options for reducing transfusions
A review looked at trials comparing erythropoiesis-stimulating agents (EPO), iron, combination therapy with iron and EPO, hypoxia-inducible factor prolyl hydroxylase inhibitor, or vitamin D3 with controls on rates of red blood cell transfusion in the ICU.
https://acphospitalist.acponline.org/archives/2023/11/22/ironepo-combination-beats-other-options-for-reducing-icu-transfusions.htm
22 Nov 2023
Guidelines offer 28 recommendations for initial management, secondary prevention of DVT and PE
Among other recommendations, the new guidelines from the American Society of Hematology suggest offering home treatment to low-risk patients with deep venous thrombosis (DVT) or pulmonary embolism (PE).
https://acphospitalist.acponline.org/weekly/archives/2020/10/21/3.htm
21 Oct 2020
COPD meds, endocarditis, and more
Recent research from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2021/04/recent-research.htm
15 Apr 2021
December issue online and in the mail
The latest issue of ACP Hospitalist covers diabetes, gabapentinoids, high-value care, burnout, and antibiotic stewardship.
https://acphospitalist.acponline.org/weekly/archives/2019/12/11/5.htm
11 Dec 2019
Sepsis cultures, resuscitation score, and more
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/04/recent-research.htm
15 Apr 2020
New data on tocilizumab, convalescent plasma, anticoagulation for COVID-19
Recent studies found that tocilizumab was potentially harmful for ICU patients, indicated that convalescent plasma works better with higher antibody titers delivered earlier, and offered conflicting findings on anticoagulation. Other research compared mortality from COVID-19 over time.
https://acphospitalist.acponline.org/weekly/archives/2021/01/27/1.htm
27 Jan 2021
Venous thromboembolism in malignancy
Patients with a VTE have more than a fourfold increased risk for cancer compared with the general population. In patients with a known malignancy, the annual incidence of VTE is 1 in 200.
https://acphospitalist.acponline.org/archives/2017/03/expert-analysis-vte-malignancy.htm
15 Mar 2017
Recent Research
Women and stroke care, frailty as a predictor of cardiac surgery outcome, cost-effectiveness of heart failure therapy, and more
https://acphospitalist.acponline.org/archives/2017/01/recent-research.htm
15 Jan 2017
Clot recurrence and major bleeds similar with tinzaparin or warfarin, study finds
Cancer patients with venous thromboembolism had similar mortality, but fewer symptomatic deep vein thromboses after 6 months of low-molecular-weight heparin instead of warfarin.
https://acphospitalist.acponline.org/weekly/archives/2015/08/26/1.htm
26 Aug 2015